JOURNAL OF CLINICAL VIROLOGY
Scope & Guideline
Advancing the Frontiers of Viral Research
Introduction
Aims and Scopes
- Clinical Diagnostics and Monitoring:
The journal emphasizes the development and evaluation of diagnostic assays for viral infections, including real-time PCR, serological tests, and point-of-care testing, aiming to improve early detection and monitoring of viral diseases. - Epidemiological Studies:
The journal covers a wide range of studies related to the epidemiology of viral infections, including outbreak investigations, seroprevalence studies, and the evolution of viral pathogens, providing critical insights into the spread and control of viral diseases. - Viral Pathogenesis and Treatment:
Research on the mechanisms of viral pathogenesis, host response, and the effectiveness of antiviral treatments is a core focus, facilitating a better understanding of how viruses affect human health and how to combat them. - Vaccine Development and Immunogenicity:
The journal publishes studies on vaccine efficacy, safety, immunogenicity, and the impact of vaccination on viral transmission, particularly in the context of emerging viral threats. - Emerging and Re-emerging Viruses:
There is a strong emphasis on research related to newly identified viruses and the resurgence of previously controlled viral infections, reflecting the journal's commitment to addressing global health challenges.
Trending and Emerging
- COVID-19 Research:
A significant increase in research related to SARS-CoV-2, including studies on diagnostics, treatment, vaccine efficacy, and epidemiological impacts, underscores the pandemic's influence on the field. - Molecular Diagnostics and Point-of-Care Testing:
There is a notable trend towards developing and validating rapid, sensitive molecular diagnostic tests, including point-of-care assays that enhance accessibility and speed of viral detection. - Viral Genomics and Evolution:
The journal is witnessing a rise in studies focused on viral genomics, phylogenetics, and the evolutionary dynamics of viruses, which are crucial for understanding outbreaks and developing targeted interventions. - Immunology and Host Response:
Research exploring the immune response to viral infections and the implications for treatment strategies has gained traction, particularly in the context of vaccine development and immunotherapy. - Global Health and One Health Approach:
Emerging studies that adopt a One Health perspective, integrating human, animal, and environmental health in the context of viral infections, are becoming increasingly relevant, reflecting a holistic approach to addressing viral threats.
Declining or Waning
- Traditional Virology Techniques:
Over the years, there has been a decline in studies focusing solely on traditional virology techniques, such as basic culture and isolation methods, as the field moves towards more advanced molecular techniques and rapid diagnostics. - Non-Viral Co-Infections:
Research on co-infections with non-viral pathogens has become less prominent, as the focus has shifted to understanding the specific impacts and management of viral infections, particularly in the context of COVID-19. - Historical Epidemiological Studies:
There has been a noticeable reduction in the publication of retrospective studies on historical viral outbreaks, as current research increasingly prioritizes real-time data and responses to ongoing viral threats.
Similar Journals
VIRUS RESEARCH
Illuminating the complex world of viral pathogens.VIRUS RESEARCH is a leading journal dedicated to the field of virology, published by Elsevier, and has been a cornerstone for researchers, professionals, and students since its inception in 1984. With an impressive impact factor, the journal is highly regarded, holding a Q2 category ranking in both Cancer Research and Infectious Diseases, as well as in Virology for 2023. Based in the Netherlands, it publishes high-quality, peer-reviewed articles that explore the intricate relationships between viruses and their hosts, novel therapeutic strategies, and advancements in virus biology. Researchers will find that it ranks 49th in Medicine - Infectious Diseases and 19th in Immunology and Microbiology - Virology according to Scopus, signifying its significant contribution and relevance in the academic world. VIRUS RESEARCH facilitates a platform for sharing groundbreaking discoveries, forming a vital part of the global scientific community, making it an essential read for those involved in the study of viral pathogens and their implications in medicine and biochemistry.
VIROLOGIE
Connecting researchers in the global virology community.VIROLOGIE is a prominent international journal dedicated to advancing the field of virology and infectious diseases, published by John Libbey Eurotext Ltd. Since its inception in 1997, this journal has provided a platform for researchers and professionals to disseminate their findings on various aspects of virology, including the pathogenesis, epidemiology, and treatment of viral infections. Despite its current ranking in Q4 for both Infectious Diseases and Virology categories, the journal remains a valuable resource for emerging research and novel insights. The ISSN for the journal is 1267-8694, and it is based in France. VIROLOGIE is committed to upholding rigorous academic standards and fosters an inclusive scholarly community, making it an essential read for those pursuing knowledge and advancements in the ever-evolving landscape of virology. While the journal does not currently offer open access options, it continues to contribute significantly to the global discourse on viral research through its diverse range of published studies.
VIROLOGY
Pioneering Research in Virology and PathogenesisVirology, published by Academic Press Inc. Elsevier Science, is a prominent journal dedicated to advancing the knowledge and understanding of viral biology and pathogenesis since its inception in 1955. With a distinguished impact factor and recognized as a Q2 journal in the field of Virology for 2023, it ranks 38 out of 80 in the Scopus database for Immunology and Microbiology, placing it in the 53rd percentile among similar publications. This esteemed journal provides a platform for groundbreaking research, critical reviews, and comprehensive studies that contribute to our global understanding of viruses and their impact on health and disease. Although currently not an open-access journal, it remains accessible to a wide audience of researchers, professionals, and students who are keen to explore the latest advancements in virological research. The journal's scope encompasses a diverse range of topics, ensuring that it serves as an essential resource for anyone engaged in virology and related biomedical fields.
JOURNAL OF MEDICAL VIROLOGY
Transforming Knowledge: Where Virology Meets Innovation.JOURNAL OF MEDICAL VIROLOGY is a prestigious academic publication dedicated to advancing the field of virology and infectious diseases. Published by WILEY, this journal has established itself as a cornerstone within the scientific community since its inception in 1977, and it will continue to provide cutting-edge research until 2024. With an impressive impact factor that places it in the Q1 quartile for both Infectious Diseases and Virology, the journal ranks 14 out of 344 in Medicine - Infectious Diseases and 6 out of 80 in Immunology and Microbiology - Virology according to Scopus metrics. Its focus encompasses a broad spectrum of topics, including viral pathogenesis, diagnostics, treatment strategies, and epidemiology, making it an essential resource for researchers, clinicians, and students alike. Although not an open-access journal, it provides valuable insights and accessible content for subscribers and libraries. The ongoing commitment to high-quality peer-reviewed articles makes JOURNAL OF MEDICAL VIROLOGY a vital platform for disseminating knowledge and fostering innovation in virology and related fields.
Virology Journal
Driving knowledge forward in the fight against viral diseases.Virology Journal, published by BMC, stands as a prominent open-access platform since 2004, dedicated to advancing the field of virology and infectious diseases. With its E-ISSN: 1743-422X, this journal is based in the United Kingdom and strives to disseminate high-quality research that enhances our understanding of viral pathogens and their interactions with hosts. Recognized with a Q1 classification in the category of Infectious Diseases and a Q2 in Virology for 2023, Virology Journal holds significant standing in the academic community, ranking #82/344 in Medicine - Infectious Diseases and #26/80 in Immunology and Microbiology - Virology. Its commitment to open access ensures that cutting-edge research is freely available to researchers, professionals, and students worldwide, fostering collaboration and innovation in the fight against viral diseases. The journal aims to publish original research articles, reviews, and commentaries that will stimulate discourse and spark new ideas within the virology community.
Tumour Virus Research
Empowering discoveries in virology and oncology.Tumour Virus Research, an esteemed journal published by Elsevier, serves as a vital resource in the fields of cancer research, infectious diseases, and virology. With an impact factor reflective of its influence and recognized as a Q2 journal in multiple categories as of 2023, it rigorously presents high-impact research dedicated to the understanding of viral pathogens in tumorigenesis. Since its transition to an Open Access model in 2021, the journal has enhanced accessibility, empowering researchers and the academic community globally to explore cutting-edge findings. The journal covers a broad scope, encompassing the intricate interactions between viruses and cancer biology, which is crucial for developing novel therapeutic strategies. With a commitment to advancing scientific knowledge, Tumour Virus Research welcomes submissions that push the boundaries of current understanding and contribute to the ongoing battle against virus-mediated cancers, making it an indispensable publication for professionals, researchers, and students in the field.
Frontiers in Virology
Disseminating Knowledge for a Healthier TomorrowFrontiers in Virology, published by FRONTIERS MEDIA SA, is an innovative open-access journal dedicated to advancing the understanding of viral biology, pathogenesis, surveillance, and control strategies. With the rapid evolution of viral threats, this journal serves as a critical platform for researchers, professionals, and students to disseminate and access high-quality research, reviews, and perspectives in virology. The journal places a strong emphasis on interdisciplinary approaches, promoting collaborative efforts that drive breakthroughs in the field. While the specific impact factor and H-index details are currently unavailable, Frontiers in Virology is committed to rigorous peer review and integrity in scientific publishing. Authors and readers will benefit from the extensive reach provided by open access, making groundbreaking insights available to a global audience, thus contributing significantly to the ongoing dialogue in virology and public health.
Journal of Virus Eradication
Catalyzing breakthroughs in epidemiology and immunology.Welcome to the Journal of Virus Eradication, a premier publication dedicated to advancing the field of virology and infectious disease research. Published by MEDISCRIPT LTD, this journal provides a vital platform for sharing cutting-edge research findings in key areas including epidemiology, immunology, and public health. With an impressive classification of Q2 in Epidemiology and Infectious Diseases for 2023, this journal exemplifies a commitment to high-quality scholarship and impactful research. The Journal of Virus Eradication is instrumental in disseminating knowledge that tackles viral threats, contributing to global health initiatives aimed at virus containment and eradication. Researchers, professionals, and students alike will find this journal an invaluable resource, making significant contributions to the scientific community and society at large.
Future Virology
Fostering Collaboration for Viral BreakthroughsFuture Virology, published by Future Medicine Ltd, is an essential journal dedicated to advancing the understanding of virology in the contemporary scientific landscape. With an ISSN of 1746-0794 and an E-ISSN of 1746-0808, this journal serves as a platform for researchers and practitioners in the field to publish high-quality, peer-reviewed articles that explore novel discoveries, innovative therapeutic strategies, and the implications of viral research on global health. Operating from the United Kingdom and maintaining a commitment to rigorous scientific inquiry, Future Virology is categorized in the Q4 Quartile for Virology according to the latest Scopus rankings, with a position of Rank #48/80 and a percentile of 40th in the Virology category. Although it currently does not offer open access, the journal strives to disseminate critical insights that benefit a wide range of professionals, researchers, and students engaged in virology and related fields. By bridging the gap between basic research and practical applications, Future Virology plays a crucial role in fostering innovation and collaboration in the ever-evolving virology landscape.
ANTIVIRAL RESEARCH
Elevating the Standards of Antiviral TherapyANTIVIRAL RESEARCH, published by Elsevier, stands at the forefront of the study of antiviral agents and therapy, with a dedicated focus on advancing the understanding of viral infections and their mechanisms. The journal is recognized within the top tier of academic publications, belonging to the prestigious Q1 category in both Pharmacology and Virology as of 2023, ranking 12th out of 313 in Pharmacology and 11th out of 80 in Virology according to Scopus metrics, reflecting its significant impact in the field. With a long-standing history since its inception in 1959, it continues to serve as an essential platform for researchers and health professionals alike, sharing critical findings that drive innovation in antiviral therapeutics. Although it does not currently offer open access options, the journal’s rigorous peer-review process ensures that every published article meets high academic standards, providing invaluable insights for those dedicated to enhancing public health through virology research.